Shoulder Innovation’s reverse arthroplasty system cleared by FDA

Shoulder Innovation’s InSet reverse shoulder arthroplasty system received FDA 510(k) clearance, the company said Aug. 23. 

Advertisement

The system uses artificial intelligence for preoperative planning. Instrumentation for six different products is integrated into one tray, making the system optimal for outpatient settings. It’s reportedly the only true fully convertible humeral inlay system.

“Not only does our system provide a reduced implant and instrument footprint, but more importantly, the surgeon has access to our primary total shoulder and reverse shoulder including our innovative primary InSet and InSet Plus glenoid technology all in one place,” Chief Commercialization Officer David Blue said. “This convertible system is game-changing and efficient. The InSet Platform simplifies shoulder replacement technology in order to improve outcomes.”

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.